CAPTRUST Financial Advisors
ZOM

CAPTRUST Financial Advisors’s Zomedica Corp. ZOM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,615
Closed -$3.38K – 2430
2024
Q3 		$3.38K Buy
+24,615
New +$3.45K ﹤0.01% 2286
2022
Q3 		– Sell
-8,500
Closed -$2K – 4636
2022
Q2 		$2K Buy
8,500
+1,000
+13% +$255 ﹤0.01% 4575
2022
Q1 		$3K Hold
7,500
– – ﹤0.01% 4429
2021
Q4 		$2K Sell
7,500
-4,000
-35% -$1.8K ﹤0.01% 4493
2021
Q3 		$6K Sell
11,500
-50,000
-81% -$29.5K ﹤0.01% 3907
2021
Q2 		$51K Buy
61,500
+53,000
+624% +$49.4K ﹤0.01% 2506
2021
Q1 		$13K Buy
+8,500
New +$13.9K ﹤0.01% 3306
2020
Q3 		– Sell
-4,346
Closed -$1K – 3363
2020
Q2 		$1K Buy
+4,346
New +$828 ﹤0.01% 2785

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAPTRUST Financial Advisors's ZOM Position: Q4 2024 in Review

CAPTRUST Financial Advisors sold out of Zomedica Corp. (ZOM) in Q4 2024, closing a stake of 24,615 shares — an estimated $3.38K sold.

CAPTRUST Financial Advisors first reported a position in ZOM in Q2 2020 and held it in 8 quarters. The position peaked at $51K in Q2 2021. 93 funds tracked by Wall St. Rank hold ZOM as of Q4 2024.

  • CAPTRUST Financial Advisors reported no remaining Zomedica Corp. position as of Q4 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 24,615 Zomedica Corp. shares in Q4 2024, an estimated $3.38K.
  • CAPTRUST Financial Advisors first reported a position in Zomedica Corp. in Q2 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Zomedica Corp. position peaked at $51K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.